clesrovimab

FDA Drug Profile

Drug Details

Generic Name
clesrovimab
Brand Names
N/A
Application Number
Sponsor
Patheon Manufacturing Services LLC
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
N/A
Active Ingredients
CLESROVIMAB

Indications and Usage

1 INDICATIONS AND USAGE ENFLONSIA is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season. ENFLONSIA is a respiratory syncytial virus (RSV) F protein-directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season. ( 1 )